-
Article
Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS pat...
-
Article
Open AccessPhase I clinical trial results of aceneuramic acid for GNE myopathy in Japan
GNE myopathy (distal myopathy with rimmed vacuoles) is a rare intractable muscle disease caused by the mutations in GNE gene, with no therapeutic agents at present. The mutations in GNE (UDP-N-acetylglucosamine 2...
-
Article
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin
The newly recognized ataxia–ocular apraxia 1 (AOA1; MIM 208920)1,2,3,4 is the most frequent cause of autosomal recessive ataxia in Japan2,4,5,6,7,8,9 and is second only to Friedreich ataxia in Portugal10. It shar...
-
Article
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy
Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that we have mapped to human chromosome 2p13. We recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig...
-
Article
Mild ALS in Japan associated with novel SOD mutation